Clinical Trial Update: Timing for Bone Marrow Mononuclear Cells After Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 study evaluating the timing of bone marrow mononuclear cell therapy after acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED